After careful consideration of the concerns around COVID-19, the BCASA and Fourth Annual Boston Pharmaceutical Symposium's Scientific Committee decided to cancel the Fourth Annual Boston Pharmaceutical Symposium. The planned agenda and other details are shown below.



We invite you all to attend the Fourth Annual Boston Pharmaceutical Symposium that will take place on Friday, May 8, 2020, on the campus of Pfizer, Building 2, Kendall Sq., 610 Main Street, Cambridge, MA. The event is organized by the Boston Chapter of the American Statistical Association in collaboration with researchers from several pharmaceutical companies in the Boston area. Financial support from Cytel, Pfizer and Takeda is gratefully acknowledged. The symposium will feature presentations by prominent researchers and industry professionals, and will include refreshments and networking opportunities. As an annual event, the Boston Pharmaceutical Symposium provides a unique venue for sharing statistical applications and research in the biotech-pharma industry, and building connections among all colleagues of the Greater Boston area engaged in the industry statistical practice. We welcome the participation from industry statisticians, academia researchers, as well as university students and any professionals interested in pharmaceutical statistical topics. Please contact Dr. Olga Vitek via o.vitek@northeastern.edu for general inquiries.

Date: Friday May 8, 2020.

Symposium location: Pfizer, Building 2, Kendall Sq, 610 Main Street, Cambridge, MA 02139

Schedule and Confirmed Speakers:


8:45am-9:00am: Welcome address from Pfizer

9-9:30: Keynote, Sandeep Menon, SVP, Pfizer

9:30-10:00: Andrew Bean, Principal Biostatistician, Novartis

10:00-10:30: Break

10:30-11:00: Mike Hale, VP and Chief Statistical Scientist, Takeda

11:00-11:30: Charlie Cao, Senior Director, Biogen

11:30-12:00: Yannis Jemiai, Chief Scientific Officer, Cytel 

12:00-1:30pm Lunch and posters

1:30-2:00: Keynote: Anne Heatherington, SVP, Head of Data Science, Takeda

2:00-2:30: Bo Jin, Executive Director, Boston Biomedical

2:30-3:00: Break

3:00-3:30: Yuan Ji, University of Chicago

3:30-4:00: Meijuan Li, VP of Biostatistics and bioinformatics, Foundation Medicine; formerly deputy director at FDA/CDRH division of Biostatistics

4:00-4:30: Geoffrey Grove, Senior Product Manager, Cytel


Scientific Committee:

Alyssa Biller, Cytel

Wenting Cheng, Biogen

Tim Clough, Novartis

Fang Yang, Novartis

Geoffrey Grove, Cytel Inc

Hrishikesh Kulkarni, Alexion

Zhonggai (Kevin) Li, Boston Biomedical

Jianchang Lin, Takeda

Jameson Luks, Cytel

Olga Vitek, Northeastern University

Huyuan Yang, Boston Biomedical

Weidong Zhang, Jounce Therapeutics

Ling Wang, Pfizer

We thank our colleagues at Pfizer for planning to host this event. We thank Cytel and Takeda for planning to provide financial support for this event.